Molecular Features and Antimicrobial Susceptibilities of IStreptococcus equi/I ssp. Iequi/I Isolates from Strangles Cases in Indonesia

• Published in: Veterinary sciences Vol. 10; no. 1
• Main Authors: Rotinsulu, Dordia Anindita, Ewers, Christa, Kerner, Katharina, Amrozi, Amrozi, Soejoedono, Retno Damayanti, Semmler, Torsten, Bauerfeind, Rolf
• Format: Journal Article
• Language: English
• Published: MDPI AG 01-01-2023
• Subjects: Animal welfare; Epidemiology; Ethylenediaminetetraacetic acid; Newton, J.R; Penicillin G; Germany; Indonesia
• ISSN: 2306-7381; 2306-7381
• DOI: 10.3390/vetsci10010049

Strangles is a highly infectious disease of equines caused by Streptococcus equi ssp. equi (S. equi equi). The objective of this study was to characterize S. equi equi isolates obtained from suspected strangles cases in Indonesia using whole genome sequence-based analyses and antimicrobial susceptibility testing. Isolates were recovered from seven diseased horses on four farms in three different provinces in 2018. All these S. equi equi isolates were classified as ST179 and carried seM allele 166. Isolates differed from each other by only 2 to 14 core genome (cg) SNPs and built an exclusive sub-cluster in Bayesian Analysis of Population Structure cluster 2 (BAPS-2) of the cgMLST scheme. All isolates revealed predicted amino acid sequence identity to seven and high similarity to one of the eight antigen fragments contained in the Strangvac[sup.®] recombinant subunit vaccine. Furthermore, all isolates were susceptible to beta-lactam antibiotics penicillin G, ampicillin, and ceftiofur. Our data suggest that the horses referred to in this study were affected by strains of the same novel sublineage within globally distributed BAPS-2 of S. equi equi. Nevertheless, penicillin G can be used as a first-choice antibiotic for treatment and Strangvac[sup.®] may also be protective against these strains. Strangles, caused by Streptococcus equi ssp. equi (S. equi equi), is a highly infectious and frequent disease of equines worldwide. No data are available regarding the molecular epidemiology of strangles in Indonesia. This study aimed to characterize S. equi equi isolates obtained from suspected strangles cases in Indonesia in 2018. Isolates originated from seven diseased horses on four different farms located in three provinces of Indonesia. Whole genome sequences of these isolates were determined and used for seM typing, multilocus sequence typing (MLST), and core genome MLS typing (cgMLST). Genomes were also screened for known antimicrobial resistance genes and genes encoding for the recombinant antigens used in the commercial Strangvac[sup.®] subunit vaccine. All seven S. equi equi isolates from Indonesia belonged to ST179 and carried seM allele 166. Isolates differed from each other by only 2 to 14 cgSNPs and built an exclusive sub-cluster within the Bayesian Analysis of Population Structure (BAPS) cluster 2 (BAPS-2) of the S. equi equi cgMLST scheme. All isolates revealed predicted amino acid sequence identity to seven and high similarity to one of the eight antigen fragments contained in Strangvac[sup.®]. Furthermore, all isolates were susceptible to beta-lactam antibiotics penicillin G, ampicillin, and ceftiofur. Our data suggest that the horses from this study were affected by strains of the same novel sublineage within globally distributed BAPS-2 of S. equi equi. Nevertheless, penicillin G can be used as a first-choice antibiotic against these strains and Strangvac[sup.®] may also be protective against Indonesian strains.